Investor profile
Aurea has backed 2 European tech companies across 2 funding rounds between 2024 and 2026, joining rounds totalling €33M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: Auréa Group
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| NUCLIDIUM | Switzerland | 1 | €29M |
| Scandinavian Biolabs | Denmark | 1 | €4.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| NUCLIDIUM | Series B | €29M | 2026-05 |
| Scandinavian Biolabs | Other | €4.0M | 2024-09 |
